comparemela.com
Home
Live Updates
Nektar Regains Full Rights Of REZPEG From Eli Lilly, Plans To Initiate Phase 2b Study : comparemela.com
Nektar Regains Full Rights Of REZPEG From Eli Lilly, Plans To Initiate Phase 2b Study
(RTTNews) - Nektar Therapeutics (NKTR) Thursday announced that it will be regaining the full rights to REZPEG from Eli Lilly and Company. The comp...
Related Keywords
Eli Lilly
,
Howardw Robin
,
comparemela.com © 2020. All Rights Reserved.